{"symbol":"AMGN","fiscalQuarter":"Q4-2025","reportDate":"2026-02-03","reportTime":"AMC","status":"reported","company":{"name":"Amgen Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2025","postBrief":{"headline":"Amgen Beats on EPS, Stock Down 1.77%","keyNumbers":[{"metric":"EPS","actual":"$5.29","expected":"N/A","surprise":"+11.18%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on delivering value to our shareholders."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Amgen's earnings report showed a positive surprise in EPS, indicating stronger-than-expected profitability. However, the stock reacted negatively, declining by 1.77%. The lack of revenue data and forward guidance may have contributed to investor uncertainty.","metaDescription":"Amgen Inc (AMGN) Q4 2025 earnings: EPS beat by 11.18%. Stock down 1.77%. Full breakdown."}}